Pharmacotherapeutics in Women’s Health - Hormone Replacement Therapy

Join our CE course for Nurses and Nurse Practitioners (NPs) on Pharmacotherapeutics in Women’s Health - Hormone Replacement Therapy (HRT) to gain an in-depth understanding of hormonal contraceptives and their broader applications in women's health. This course explores the full spectrum of hormonal contraceptive options, including monophasic, biphasic, triphasic, and progestin-only formulations, focusing on their indications, mechanisms of action, and effective clinical use. Learners will also receive comprehensive instruction on emergency contraception and its timely administration. Beyond contraception, this CE activity covers the fundamentals of hormone replacement therapy, including when and how to initiate HRT to manage menopausal symptoms such as hot flashes, night sweats, mood swings, and osteoporosis. Nurses and NPs will develop confidence in counseling patients about the risks, benefits, and safety considerations of hormone-based therapies. Through evidence-based guidance, this program aims to empower healthcare professionals to deliver informed, empathetic, and personalized care in the evolving field of women’s health. Whether in clinical, primary, or community care settings, this course will enhance your pharmacological knowledge to optimize treatment strategies and improve patient outcomes for reproductive and menopausal care.

Learners will also receive comprehensive instruction on emergency contraception and its timely administration. Beyond contraception, this CE activity covers the fundamentals of hormone replacement therapy, including when and how to initiate HRT to manage menopausal symptoms such as hot flashes, night sweats, mood swings, and osteoporosis.

Nurses and NPs will develop confidence in counseling patients about the risks, benefits, and safety considerations of hormone-based therapies. Through evidence-based guidance, this program aims to empower healthcare professionals to deliver informed, empathetic, and personalized care in the evolving field of women’s health.

Whether in clinical, primary, or community care settings, this course will enhance your pharmacological knowledge to optimize treatment strategies and improve patient outcomes for reproductive and menopausal care.

Educational Objectives

• Identify and differentiate the various types of hormonal contraceptives, including their specific indications for use in clinical practice.
• Explain the pharmacological mechanisms of action for monophasic, biphasic, triphasic, and progestin-only contraceptives.
• Describe appropriate uses, timing, and safety considerations for emergency contraception.
• Evaluate the benefits, risks, and common side effects associated with various contraceptive options to support informed decision-making.
• Understand the core principles of hormone replacement therapy (HRT) and its evidence-based application in managing menopausal symptoms.

Who Should Do This Course?

This continuing education course is specifically designed for Registered Nurses (RNs) and Nurse Practitioners (NPs) involved in women's health, reproductive care, and primary care. It is particularly suitable for healthcare professionals seeking to meet state-specific license renewal requirements in pharmacology-related topics. The course fulfills the mandatory CE requirements in the following U.S. states:

• Advanced Pharmacology – Nursing: Ohio, Alaska
• Pharmacotherapeutics – Nursing: Hawaii, Louisiana, Oklahoma, West Virginia, Connecticut, Arkansas, Illinois, Nebraska, South Carolina, Texas, Washington, Wisconsin
• Pharmacology – Nursing: Alabama, Indiana

This course is ideal for those involved in prescribing, administering, or counseling patients on hormonal contraceptives and hormone replacement therapies.

Did You Know?

• According to the CDC, nearly 65% of women aged 15-49 in the U.S. use some form of contraception.
• Hormonal contraceptives not only prevent pregnancy but also help manage conditions like PCOS and endometriosis.
• The North American Menopause Society (NAMS) recommends individualized HRT based on age, health status, and personal preferences.
• Combined hormonal contraceptives may reduce the risk of ovarian and endometrial cancers by up to 50%.
• Emergency contraception can prevent up to 95% of pregnancies if taken within five days of unprotected intercourse.